Viewing Study NCT00005903


Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2026-01-01 @ 6:38 PM
Study NCT ID: NCT00005903
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 2000-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module